3D Cell Culture Market Worth $2.6 Billion by 2027- Global Trends, Growth, Share Analysis, Leading Players, Business Opportunities
In July 2021, Lonza Group AG (Switzerland) and CN Bio Innovations (UK) announced a distribution agreement providing pre-validated hepatocytes for use on CN Bio’s innovative PhysioMimix Organ-On-a-Chip (OOC) range of single and multi-organ microphysiological systems (MPS).
View full press release